It is fair to say that the year 2024 was a 'dramatic' one, in which two major life-threatening epidemics were recorded but safely controlled and key achievements were registered in Rwanda's efforts to ...
The approval of TEPOXX in Japan marks another significant milestone in our mission to expand access to this critical ...
On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...
TPOXX is approved in the U.S. and Canada for the treatment of smallpox. In the European Union and United Kingdom, marketed as Tecovirimat-SIGA, it is approved for the treatment of smallpox, mpox, ...
Siga Technologies (SIGA)’ antiviral treatment Tepoxx, has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, as ...
SIGA Technologies (SIGA) stock gains as Japan approves antiviral Tepoxx as a treatment for orthopoxviruses including mpox.
In 2024, the Bulletin covered zombie pathogens emerging from a thawing Arctic, synthetic viruses, the pandemic that crippled ...
The Ministry of Health has urged Kenyans to exercise caution amid a new wave of MPOX infections spreading rapidly across the ...
It was a year in health news that will be hard to forget.As blockbuster weight-loss drugs known as GLP-1s made a sizab ...
The year 2024 was pivotal for Kenya’s healthcare sector, marked by ambitious reforms and persistent challenges. Key ...
Two deaths from Nipah virus, a zoonotic pathogen with a high mortality rate, were reported in Kerala, India in June and ...
A Colorado man was arrested on suspicion of bias-motivated crimes, second degree assault and harassment for a Dec. 18 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback